This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Arkansas. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations by Jake Jones in Engineered FGF1 and FGF2 Compositions
Introduction
Jake Jones is an innovative inventor based in Fayetteville, AR (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. His work focuses on enhancing the stability and effectiveness of growth factors that are crucial for various medical applications.
Latest Patents
Jake Jones holds a patent for "Engineered FGF1 and FGF2 compositions and methods of use thereof." This patent includes engineered FGF1 and FGF2 polypeptides, polynucleotides encoding these polypeptides, and DNA constructs, vectors, and compositions that incorporate these engineered polypeptides. The engineered FGF1 and FGF2 polypeptides are noted for their increased stability compared to their wild-type counterparts. This advancement may lead to more effective treatments for conditions where FGF1 and FGF2 are beneficial, such as in wound healing. He has 1 patent to his name.
Career Highlights
Jake Jones is affiliated with the University of Arkansas, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Suresh Kumar Thallapuranam and Shilpi Agarwal. Their collaborative efforts enhance the research environment and foster innovation in their projects.
Conclusion
Jake Jones is a prominent inventor whose work on engineered FGF1 and FGF2 compositions holds promise for advancing medical treatments. His contributions to biotechnology are paving the way for more effective therapeutic solutions.